Stockreport

IMNN: OVATION 2 Translational Data Shows IMNN-001 Alters Tumor Microenvironment… [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF Translational Data from OVATION 2 Trial Presented at AACR Special Conference On September 22, 2025, Imunon, Inc. (NASDAQ:IMNN) announced that new translational data f [Read more]